NOV 11, 2021 7:00 AM PST

Some Patients Left Vulnerable to COVID Even After Getting Vaccinated

WRITTEN BY: Tara Fernandes

Global vaccination efforts continue in the backdrop of the ongoing pandemic. However, new studies demonstrate how several factors strongly influence the extent of immune protection offered by vaccines. Among them are the individual’s underlying health status and the medications they are currently taking.

study presented at the American College of Rheumatology’s annual meeting provides evidence that patients taking immunosuppressive therapies to treat rheumatoid arthritis are more susceptible to COVID infections, even if they are vaccinated.

Interestingly, the study showed that even patients on potent immunosuppressants (administered to weaken the immune system to reduce the impact of autoimmune diseases on the body) could mount antibody responses against SARS-CoV-2. After getting their shots, the researchers found that nearly 90 percent of the study participants on a glucocorticoid or B-cell depleting therapy produced antibodies against the coronavirus.

However, what was eye-opening for the researchers was that patients on immunosuppressants produced about three times lower antibody levels than those not taking these drugs. 

The Washington University School of Medicine St. Louis team found that B-cell depleting agents, glucocorticoids, and JAK inhibitors were among the medications most likely to inhibit antibody responses. Their analyses revealed that B-cell depleting treatments were the worst, resulting in a whopping 36-fold reduction in humoral responses. 

“These results demonstrate that the risk of suboptimal antibody responses is not uniform across rheumatic disease patients on immunosuppression, and certain populations are at much higher risk of poor or absent responses,” said one of the study leads, Alfred Kim. 

These data illustrate the importance of helping these vulnerable patients achieve more robust immune protection against the coronavirus. For example, they might pause their immunosuppression medicines around the time of vaccinations or receive additional vaccination doses to boost protection.

About the Author
PhD
Interested in health technology and innovation.
You May Also Like
FEB 10, 2022
Immunology
Fresh Insights Into Gut Inflammation
FEB 10, 2022
Fresh Insights Into Gut Inflammation
We live in harmony with around 200 trillion microorganisms that make up the human microbiome. These friendly microbes he ...
FEB 11, 2022
Plants & Animals
New Prostate Cancer Drug Effective in Dogs, Promising for Humans
FEB 11, 2022
New Prostate Cancer Drug Effective in Dogs, Promising for Humans
Prostate cancer affects about one in eight men each year, and is one of the most common types of cancer in men). Researc ...
MAR 14, 2022
Cancer
Expanded Approval for the PD-1 Blocking Immunotherapy Opdivo
MAR 14, 2022
Expanded Approval for the PD-1 Blocking Immunotherapy Opdivo
Over the past decade, immunotherapy drugs known as immune checkpoint inhibitors have emerged as a promising an ...
APR 03, 2022
Health & Medicine
Deltacron: How Dangerous Is It?
APR 03, 2022
Deltacron: How Dangerous Is It?
It turns out you can have Delta and Omicron at the same time, and it can lead to the recombinant variant deltacron. Firs ...
APR 22, 2022
Immunology
How Diet Affects Your Immune System
APR 22, 2022
How Diet Affects Your Immune System
Our immune system plays a vital role in our bodies, as it is literally responsible for keeping us healthy and free of ha ...
APR 27, 2022
Clinical & Molecular DX
Asthma Risk Increased in Children Conceived with Infertility Treatment
APR 27, 2022
Asthma Risk Increased in Children Conceived with Infertility Treatment
Asthma is a disease characterized by difficulty breathing, and an asthma attack can bring on bouts of coughing and wheez ...
Loading Comments...